AlphaMa

Suzhou AlphaMa Biotechnology Co., Ltd. is an innovative drug discovery company driven by big data and artificial intelligence. We utilize an AI technology platform and an integrated AI-powered DEL platform (DELAI) to develop specific computational models and algorithmic logic in order to quickly identify active molecules for target validation, as well as the subsequent optimization of active molecules into lead compounds. Our goal is to accelerate the drug discovery process using AI and DEL technologies to bring accessible clinical-demand drugs to society. We sincerely look forward to collaborating with partners to achieve this goal together.